Analyst Expects Nurix Therapeutics Inc (NASDAQ: NRIX) To Make Big Moves

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NASDAQ listed company, NRIX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Nurix Therapeutics Inc is $1.38B. A total of 0.53 million shares were traded on the day, compared to an average of 915.33K shares.

In the most recent transaction, Ring Christine sold 5,760 shares of NRIX for 19.50 per share on Jan 02 ’25. After the transaction, the Chief Legal Officer now owns 28,084 company shares. In a previous transaction on Jan 02 ’25, CHRISTINE RING bought 5,760 shares at 18.84 per share.

Among the insiders who sold shares, Ring Christine disposed of 5,760 shares on Dec 02 ’24 at a per-share price of $21.73. This resulted in the Chief Legal Officer holding 28,084 shares of NRIX after the transaction. In another insider transaction, CHRISTINE RING bought 5,760 shares at $22.11 per share on Dec 02 ’24.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, NRIX has a high of $29.56 and a low of $7.65.

As of this writing, NRIX has an earnings estimate of -$0.67 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of -$0.54 per share and a lower estimate of -$0.89.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NRIX’s latest balance sheet shows that the firm has $295.72M in Cash & Short Term Investments as of fiscal 2021. There were $13.04M in debt and $66.26M in liabilities at the time. Its Book Value Per Share was $5.62, while its Total Shareholder’s Equity was $342.30M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NRIX is Buy with a score of 4.76.

Most Popular

Related Posts